We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights. Usually, bowel cancer arises from benign growths of tissue, known as polyps. Over time, the disease can spread to surrounding tissues; thus the sooner it’s diagnosed, the better the chance of a […]
Home »
Three-drug combo improves survival period of bowel cancer patients: Study
The data from the results of a phase-3 clinical trial noted that the three-drug combination, encorafenib, binimetinib and cetuximab, should replace chemotherapy for patients with metastatic colorectal cancer who have a BRAF gene flaw. A targetted three-drug combination therapy could increase the survival period of patients with advanced bowel cancer for overall nine months as […]